Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New Press Release - Theralase(R) Extends Warrants

<< Previous

Bullboard Posts

Next >>

Comment by Maxcitracon Nov 13, 2024 8:27am

162 Views

Post# 36309873

RE:RE:RE:RE:RE:RE:New Press Release - Theralase(R) Extends Warrants

Gooseybear wrote: You must have a low bar to believe that the Board and management have done a fine job.

Gooseybear is a strange character. He pretend to be a cancer survivor, and at the same time, he keep bashing a company, that in the future could save his life.
If you ask me ,he is a phony cancer survivor.

<< Previous

Bullboard Posts

Next >>

Debt-free cannabis company set for next stage of growth